Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
Glasgow Hearing Aid Benefit Profile was significantly higher for hearing aids fitted by audiologists following best practice
Read More »Audiologist-Fitted Hearing Aids Outperform Over-the-Counter Ones
HealthDay.com
Risk for Death, MACE Increased for Patients With Adult-Onset Type 1 Diabetes
Risk for MACE lower in adult-onset T1D versus T2D, but mortality higher from diabetic coma or ketoacidosis
Read More »Medicaid Unwinding Linked to Disruption of Chronic Medication Therapy in Youth
Pausing Medicaid eligibility determinations during COVID-19 pandemic linked to increased risk for having no prescriptions and cash-pay prescriptions
Read More »Custom Gene Editing Helps Baby With Rare Condition
By I. Edwards HealthDay ReporterFRIDAY, May 16, 2025 (HealthDay News) — A baby born with a rare and deadly genetic disease is the world’s first known patient to receive an experimental gene editing treatment designed just for him.KJ Muldoon from Clifton Heights, Pa., is thriving after the therapy to fix …
Read More »Toxic Metals Found in All Rice Samples in New Report
By I. Edwards HealthDay ReporterFRIDAY, May 16, 2025 (HealthDay News) — A new report says rice sold in U.S. stores contains toxic heavy metals, including arsenic, cadmium, lead and mercury.The report — released by Healthy Babies, Bright Futures — found arsenic in 100% of rice samples tested from stores in …
Read More »Republican Medicaid Cuts Could Cause Rural Hospital Closures, CEOs Warn HealthDay TV
By Dennis Thompson HealthDay ReporterFRIDAY, May 16, 2025 (HealthDay News) — Proposed cuts to Medicaid could be devastating to America’s rural hospitals, health care CEOs are warning in interviews with HealthDay.House Republicans have proposed an $880 billion reduction in Medicaid funding. Combined with other health care cuts, the package could …
Read More »Novo Nordisk, U.S. Biotech Company Team Up to Create Obesity Pills
By I. Edwards HealthDay ReporterFRIDAY, May 16, 2025 (HealthDay News) — Danish drugmaker Novo Nordisk is teaming up with California-based biotech Septerna to develop new pills to treat obesity, type 2 diabetes and other metabolic diseases.The deal could be worth up to $2.2 billion for Septerna. This includes more than …
Read More »Greater Sedentary Time Associated With Higher Risk for Alzheimer Disease
Association with Alzheimer disease seen in cross-sectional and longitudinal models
Read More »FDA Gives Marketing Nod to Blood Test for Diagnosing Alzheimer Disease
Noninvasive diagnostic test measures two proteins, pTau217 and β-amyloid 1-42, found in human plasma
Read More »Testosterone Use Not Tied to Gynecological Cancers in Transmasculine Individuals
No cases of endometrial, ovarian, vaginal, or vulvar cancer were seen
Read More »